Edition:
United Kingdom

OncoSec Medical Inc (ONCS.OQ)

ONCS.OQ on NASDAQ Stock Exchange Capital Market

1.61USD
9:00pm BST
Change (% chg)

$-0.03 (-1.83%)
Prev Close
$1.64
Open
$1.65
Day's High
$1.73
Day's Low
$1.60
Volume
229,203
Avg. Vol
119,136
52-wk High
$2.95
52-wk Low
$1.04

Chart for

About

OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid... (more)

Overall

Beta: 2.92
Market Cap(Mil.): $22.01
Shares Outstanding(Mil.): 21.17
Dividend: --
Yield (%): --

Financials

  ONCS.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -1.15 -- --
ROI: -105.93 0.45 14.28
ROE: -110.71 1.37 16.00

BRIEF-Oncosec Expands Relationship With Merck For Combination Of Immunopulse Il-12 And Keytruda

* ONCOSEC EXPANDS RELATIONSHIP WITH MERCK, ANNOUNCES CLINICAL COLLABORATION TO EVALUATE COMBINATION OF IMMUNOPULSE IL-12 AND KEYTRUDA FOR TRIPLE NEGATIVE BREAST CANCER

08 May 2018

BRIEF-Oncosec Medical Says Board Determined To Consolidate Roles Of CEO And President

* ONCOSEC MEDICAL INC - BOARD DETERMINED TO CONSOLIDATE ROLES OF CHIEF EXECUTIVE OFFICER AND PRESIDENT

04 May 2018

Earnings vs. Estimates